0001231919-26-001219.txt : 20260923 0001231919-26-001219.hdr.sgml : 20260923 20260923113057 ACCESSION NUMBER: 0001231919-26-001219 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260923 DATE AS OF CHANGE: 20260923 EFFECTIVENESS DATE: 20260923 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Caspian Therapeutics, Inc. CENTRAL INDEX KEY: 0002156247 ORGANIZATION NAME: EIN: 365188487 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-598559 FILM NUMBER: 261398847 BUSINESS ADDRESS: STREET 1: 4930 DIRECTORS PLACE CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: (858) 500-8800 MAIL ADDRESS: STREET 1: 4930 DIRECTORS PLACE CITY: SAN DIEGO STATE: CA ZIP: 92121 D 1 primary_doc.xml X0708 D LIVE 0002156247 Caspian Therapeutics, Inc. 4930 DIRECTORS PLACE SAN DIEGO CA CALIFORNIA 92121 (858) 500-8800 DELAWARE None None Corporation true 2026 Robert H. Spencer c/o Caspian Therapeutics, Inc. 4930 Directors Place San Diego CA CALIFORNIA 92121 Executive Officer Troy E. Wilson c/o Caspian Therapeutics, Inc. 4930 Directors Place San Diego CA CALIFORNIA 92121 Director Spike Loy c/o Caspian Therapeutics, Inc. 4930 Directors Place San Diego CA CALIFORNIA 92121 Director Biotechnology Decline to Disclose 06b false 2026-09-08 false true false 0 50000000 50000000 0 false 43 0 0 0 false Caspian Therapeutics, Inc. Robert H. Spencer Robert H. Spencer President 2026-09-23